Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 90-96, January 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, E. E.
Right arrow Articles by Kollmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, E. E.
Right arrow Articles by Kollmann, G.

Selective Chemical Protection against Radiation in Tumor-bearing Mice*

Emanuel E. Schwartz, Bernard Shapiro and George Kollmann

( Research Laboratories, Department of Radiology, Albert Einstein Medical Center, Southern Division, Philadelphia, Pa.)

The possibility of obtaining differential protection of normal and malignant tissues against radiation in tumor-bearing mice by pretreatment with 2-mercaptoethylguanidine has been investigated. Although neither the mammary tumor nor the leukemia studied appeared to be protected against local x-ray exposure at sites of transplantation, it was not possible to greatly improve the therapeutic index of whole-body x-radiation by this means. In the case of the mammary tumor the whole-body x-radiation dose that could be administered was still below the level needed to restrain tumor growth. Results obtained in the treatment of the more radiosensitive leukemia suggested that different routes of administration resulting in a more favorable metabolism and distribution of protective compound may improve these results.

* Supported by Grant #T-150 from the American Cancer Society.

Received 7/16/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.